Navigation Links
Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome
Date:1/15/2014

CAMBRIDGE, Mass., Jan. 15, 2014 /PRNewswire/ -- Zafgen, Inc., a leading biopharmaceutical company dedicated to addressing the unmet needs of severely obese patients, today announced initial results from its Phase 2a study of beloranib, a selective inhibitor of methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome (PWS), a severe form of genetic obesity.  These results showed improvements in body weight, hunger-related behaviors, and body composition, including reductions in body fat content and preserved lean body mass following four weeks of treatment. 

These changes were observed despite the increased caloric intake that was a component of this trial.  Known markers of beloranib response including those associated with cardiovascular disease risk were also improved, demonstrating that PWS patients responded to the molecular mechanism of beloranib.

"The results of this short-term proof-of-concept study are very promising and underscore our belief that beloranib has the potential to successfully treat this severe form of obesity.  To our knowledge, this study represents the largest placebo-controlled, randomized, multiple dose trial to date for obesity in this patient population, and these results bode well for further study of beloranib in patients with this devastating condition," said Thomas Hughes, Ph.D., President and Chief Executive Officer of Zafgen.

Similar to results seen in non-PWS obese patient populations, beloranib treatment in this study reduced body fat content by 8.1% vs. placebo in four weeks of treatment at the highest study dose of 1.8 mg, despite a 50% increased daily caloric allowance.  Hunger-related behaviors improved, and a trend towards overall improvement in body weight was seen, although this did not reach statistical significance, in part due to the fact that study was not powered to demonstrate these differ
'/>"/>

SOURCE Zafgen, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Zafgen Announces Initiation of Phase 2a Clinical Development with Beloranib in Obesity
2. Zafgen Secures $21 Million in Series D Financing
3. Zafgen Announces New Weight Loss and Safety Data from Phase 2 Study of Beloranib in Obesity at Obesity Week 2013
4. Zafgen Secures $45 Million in Series E Financing
5. Zafgen Appoints Chief Commercial Officer and New Member of Board of Directors
6. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
7. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
8. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
9. Misonix Announces New Distribution Agreement For Panama
10. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
11. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Aug. 28, 2014   Edison Nation Medical ... a worldwide search for product ideas to improve ... Promising ideas uncovered through the 6-month search ( ... device manufacturers and healthcare retailers with whom Edison ... of individuals age 65 and older. ...
(Date:8/28/2014)... , Aug. 28, 2014  In recognition of ... health complications from the flu, pneumonia, shingles and ... have declared September to be Senior Vaccination ... age, it is important that adults ages 65 ... their vaccinations. CVS pharmacists and MinuteClinic nurse practitioners ...
(Date:8/28/2014)... Orthopaedics, the Official Joint Replacement Products of the PGA TOUR ... to golf fans at the next stop of the FedEx ... company,s fan destination – "The Stryker Mobility Zone" – will ... TPC Boston in Norton, MA starting ... the Deutsche Bank Championship, Stryker will be providing golf fans ...
Breaking Medicine Technology:Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 2Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 3Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 4Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 5
(Date:8/28/2014)... 2014 (HealthDay News) -- Lack of sleep not only puts ... at increased risk for obesity, researchers warn. The study ... they were aged 16 and 21. Nearly one-fifth of them ... they were age 16, and this group was 20 percent ... who got more than eight hours of sleep per night ...
(Date:8/28/2014)... NJ Top Docs Presents Dr. Christophe ... NJ Top Doc, Dr. Christophe Oliveira, has just ... examiner for the department of transportation. Dr. Oliveira ... perform all drug testing for commercial drivers. , ... musculoskeletal disorders including disk herniations, spinal stenosis, muscle ...
(Date:8/28/2014)... In 2012, The Ben & Catherine Ivy Foundation ... brain cancer research projects at the Translational Genomics ... officially received the final regulatory approval from University ... for the trial can begin. , In the ... Trial," TGen and its clinical partners will lead ...
(Date:8/28/2014)... New York (PRWEB) August 28, 2014 ... mount in courts around the U.S., Bernstein Liebhard LLP ... is touting devices like Mirena as ideal birth control ... Daily Press, the authors of the study point out ... preventing pregnancy than other methods favored by this patient ...
(Date:8/28/2014)... August 28, 2014 BioProcess ... delivering cutting-edge information focused on the development ... an agreement with Pall Life Sciences to ... BioProcess International Awards – the most honorable ... , The awards allow the industry to ...
Breaking Medicine News(10 mins):Health News:Less Sleep in Teen Years Tied to More Pounds at 21 2Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 2Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 3Health News:TGen receives approval for patient enrollment in brain cancer clinical trial 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes New Study Touting IUDs as Ideal Birth Control for Teenage Girls 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes New Study Touting IUDs as Ideal Birth Control for Teenage Girls 3Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes New Study Touting IUDs as Ideal Birth Control for Teenage Girls 4Health News:Pall Life Sciences Signs on as Program Sponsor of the 2014 BioProcess International Awards 2Health News:Pall Life Sciences Signs on as Program Sponsor of the 2014 BioProcess International Awards 3
... , , , ... regulations take effect under the HITECH Act. HIPAA-covered entities, ... notify affected individuals, the Secretary of Health and Human Services ... information (PHI) is breached. With these new rules in ...
... Researchers have shown for the first time that patterns of ... cancer has started to spread in melanoma patients, and to ... much surgery, if any, is required and to predict the ... cancer congress, ECCO 15 ESMO 34 [1], in Berlin ...
... ... Home Training and Consulting Inc., an industry leader in Continuous Process Improvement ... Sigma Yellow Belt Course available for free. This will help thousands of ... also allow potential Lean Six Sigma Green Belt and Black Belt Candidates ...
... ... Software environment with Strategic,s validation toolkit , ... Cardiff-by-the-Sea, Calif. (PRWEB) September 23, 2009 -- Strategic Information ... solutions, today announced an expanded Alliance relationship with QAD Inc (Nasdaq: QADI), ...
... NEW YORK, Sept. 23 Grammy Award-winning singer-songwriter John Legend ... Nikki Beach Midtown for Project Sunshine,s fall fundraiser to benefit children ... 48" x 32" mixed media portrait of the singer that was ... charity. , , (Photo: ...
... , , IRVINE, Calif., Sept. ... Maggots(TM) in the United States, announced today that its Laboratory ... Limb Salvage conference in Washington, DC, from September 24 to ... the company,s Medical Maggots(TM) product (disinfected Phaenicia sericata ...
Cached Medicine News:Health News:Healthcare Breach Notification Rules Take Effect; ID Experts Offers Complimentary Tool to Measure Organizations' Breach Index 2Health News:Healthcare Breach Notification Rules Take Effect; ID Experts Offers Complimentary Tool to Measure Organizations' Breach Index 3Health News:Ultrasound can predict tumor burden and survival in melanoma patients 2Health News:Ultrasound can predict tumor burden and survival in melanoma patients 3Health News:Mountain Home Helps Companies Battle Tough Economic Times by Offering Free Lean Six Sigma Training 2Health News:Strategic Information Group Announces QAD Enterprise Validation Partnership 2Health News:Strategic Information Group Announces QAD Enterprise Validation Partnership 3Health News:Monarch Labs to Demonstrate Maggot Therapy at Diabetic Limb Salvage Conference 2Health News:Monarch Labs to Demonstrate Maggot Therapy at Diabetic Limb Salvage Conference 3
Delicate membrane hook/pick with hook on side of instrument for engaging membranes. 20 gauge shaft with balanced titanium handle. Dark finish for reduced glare. Left....
0.5 mm angled tip. Round knurled handle with dull finish. Tip angle: 110 degrees. Most popular size or model....
Excellent for manipulation of the intraocular lens in the capsular bag. The angled and curved shaft allows the instrument to reach across the implant and catch the optic/ haptic junction to facilitat...
Straight shaft with 0.2 mm hour glass shape tip. Round knurled handle with dull finish. Manufactured in titanium....
Medicine Products: